| Survival analysis in clinical practice: analyze your own data using an Excel workbook M Lucijanić Croatian medical journal 57 (1), 77, 2016 | 55 | 2016 |
| Pharmacist’s interventions improve time in therapeutic range of elderly rural patients on warfarin therapy: a randomized trial S Falamić, M Lucijanić, MO Hadžiabdić, S Marušić, V Bačić Vrca International journal of clinical pharmacy 40, 1078-1085, 2018 | 37 | 2018 |
| Assessing serum albumin concentration, lymphocyte count and prognostic nutritional index might improve prognostication in patients with myelofibrosis M Lucijanic, I Veletic, D Rahelic, V Pejsa, D Cicic, M Skelin, A Livun, ... Wiener klinische Wochenschrift 130, 126-133, 2018 | 35 | 2018 |
| Clinical and prognostic significance of anisocytosis measured as a red cell distribution width in patients with colorectal cancer D Kust, M Lucijanic, K Urch, I Samija, I Celap, I Kruljac, M Prpic, I Lucijanic, ... QJM, hcw223, 2017 | 35 | 2017 |
| Ultrasound grade of liver steatosis is independently associated with the risk of metabolic syndrome S Mustapic, S Ziga, V Matic, T Bokun, B Radic, M Lucijanic, S Marusic, ... Canadian Journal of Gastroenterology and Hepatology 2018, 2018 | 33 | 2018 |
| Elevated Neutrophil–to–lymphocyte-ratio and platelet–to–lymphocyte ratio in myelofibrosis: Inflammatory biomarkers or representatives of myeloproliferation itself? M Lucijanic, D Cicic, T Stoos-Veic, V Pejsa, J Lucijanic, AF Dzankic, ... Anticancer research 38 (5), 3157-3163, 2018 | 32 | 2018 |
| Effect of timing of levothyroxine administration on the treatment of hypothyroidism: a three-period crossover randomized study M Skelin, T Lucijanić, AM Liberati-Čizmek, SM Klobučar, M Lucijanić, ... Endocrine 62, 432-439, 2018 | 31 | 2018 |
| Thrombocytosis in COVID-19 patients without myeloproliferative neoplasms is associated with better prognosis but higher rate of venous thromboembolism M Lucijanic, I Krecak, E Soric, M Sedinic, A Sabljic, L Derek, O Jaksic, ... Blood cancer journal 11 (11), 189, 2021 | 30 | 2021 |
| Patients with higher body mass index treated with direct/novel oral anticoagulants (DOAC/NOAC) for atrial fibrillation experience worse clinical outcomes M Lucijanic, I Jurin, H Jurin, T Lucijanic, B Starcevic, M Skelin, ... International journal of cardiology 301, 90-95, 2020 | 30 | 2020 |
| Clinical and prognostic significance of C-reactive protein to albumin ratio in hospitalized coronavirus disease 2019 (COVID-19) patients: Data on 2309 patients from a tertiary … M Lucijanić, J Stojić, A Atić, T Čikara, B Osmani, M Barišić-Jaman, ... Wiener klinische Wochenschrift 134 (9-10), 377-384, 2022 | 29 | 2022 |
| Bradycardia during remdesivir treatment might be associated with improved survival in patients with COVID-19: a retrospective cohort study on 473 patients from a tertiary centre P Bistrovic, S Manola, M Lucijanic Postgraduate medical journal 98 (1161), 501-502, 2022 | 27 | 2022 |
| The ABC of linear regression analysis: What every author and editor should know K Baždarić, D Šverko, I Salarić, A Martinović, M Lucijanić European science editing 47, 2021 | 27 | 2021 |
| Reduced renal function strongly affects survival and thrombosis in patients with myelofibrosis M Lucijanic, D Galusic, I Krecak, M Sedinic, H Holik, V Perisa, ... Annals of hematology 99, 2779-2785, 2020 | 27 | 2020 |
| Remdesivir might induce changes in electrocardiogram beyond bradycardia in patients with coronavirus disease 2019—The pilot study P Bistrovic, M Lucijanic Journal of medical virology 93 (10), 5724, 2021 | 26 | 2021 |
| The degree of anisocytosis predicts survival in patients with primary myelofibrosis M Lucijanic, V Pejsa, O Jaksic, Z Mitrovic, C Tomasovic-Loncaric, ... Acta haematologica 136 (2), 98-100, 2016 | 26 | 2016 |
| Remdesivir use in COVID-19 patients might predispose bacteremia, matched case-control analysis M Lucijanic, T Cikara, P Bistrovic, I Papic, MO Hadziabdic, N Busic, ... Journal of Infection 85 (2), 174-211, 2022 | 25 | 2022 |
| Vaccination provides protection from respiratory deterioration and death among hospitalized COVID‐19 patients: Differences between vector and mRNA vaccines N Busic, T Lucijanic, B Barsic, I Luksic, I Busic, G Kurdija, L Barbic, ... Journal of medical virology 94 (6), 2849-2854, 2022 | 24 | 2022 |
| Rituximab with dose-adjusted EPOCH as first-line treatment in patients with highly aggressive diffuse large B-cell lymphoma and autologous stem cell transplantation in selected … V Pejša, Ž Prka, M Lucijanić, Z Mitrović, M Piršić, O Jakšić, R Ajduković, ... Croatian medical journal 58 (1), 40-48, 2017 | 24 | 2017 |
| Survival analysis, more than meets the eye M Lucijanic, M Skelin, TL Lucijanic Biochemia medica 27 (1), 14-18, 2017 | 24 | 2017 |
| Impact of pharmacotherapeutic education on medication adherence and adverse outcomes in patients with type 2 diabetes mellitus: a prospective, randomized study S Marušić, P Meliš, M Lucijanić, I Grgurević, P Turčić, PR Obreli Neto, ... Croatian medical journal 59 (6), 290-297, 2018 | 23 | 2018 |
Rajko KušecProfesor interne medicine, Sveučilište u Zagrebu, Medicinski fakultetVerified email at mef.hr
